Pharmaceutical 3D screen printing company Laxxon Medical has been selected alongside seven other high-potential companies to participate in German Accelerator's Southeast Asia Market Access Class of 2023.

German Accelerator is a global business incubator organized by German Entrepreneurship GmbH. Laxxon's participation in the programme is guided by a strategic vision to tap into the innovation-driven markets of Southeast Asia, with a focus on Singapore.

According to Helmut Kershbaumer, CEO, Laxxon Medical (a US-based startup), "Singapore's thriving healthcare, tech and financial sectors, paired with the region's demand for innovation, creates the ideal environment for Laxxon to forge new partnerships and grow our global footprint."

German Accelerator's Southeast Asia (SEA) Market Access programme functions as a globalisation liaison for companies seeking market entry and expansion in the SEA region. The programme supports companies with established businesses in Germany through customised mentorship programmes and a vast global network of industry experts, investors, and potential partners.

Laxxon's lead mentor in German Accelerator is Dr Andreas Schmidt, serial entrepreneur and Senior Vice President of Singleron Biotechnologies. "Laxxon's 3D screen printing offers pharma companies exceptional opportunities to formulate drugs in innovative ways to maximise the therapeutic effect for patients", said Schmidt.

In August, the German Accelerator Singapore team welcomed the SEA Market Access Class of 2023 for an intense two-week programme kick-off in Singapore. German Accelerator and German Entrepreneurship GmbH is funded by the German Federal Ministry for Economic Affairs and Climate Action (BMWK). Start2 Group (Formerly German Entrepreneurship Asia) is privately owned and self-funded.